Form 4: Century Therapeutics CEO Sells Shares for Tax Obligations

Century Therapeutics' President and CEO, Brent Pfeiffenberger, sold 488 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Brent Pfeiffenberger, President and CEO of Century Therapeutics, Inc. (IPSC), reported a transaction on September 8, 2025.
• He disposed of 488 shares of Century Therapeutics common stock at a price of $0.5 per share.
• The sale was automatic and not at his discretion, executed solely to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following this transaction, Pfeiffenberger beneficially owns 3,268,909 shares of Century Therapeutics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax withholding obligations upon the vesting of restricted stock units, which is a common occurrence for executive compensation and does not reflect a change in company fundamentals or executive sentiment.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs), which is a form of executive compensation and a routine event.

Negatives

• A minor reduction in direct beneficial ownership by a key executive, Brent Pfeiffenberger, by 488 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a minor, non-discretionary reduction in insider ownership, which is a common occurrence and generally not indicative of a change in company prospects or executive confidence.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations related to RSU vesting. This type of transaction is common and does not typically indicate a change in the company's fundamentals or the executive's confidence, thus not warranting a change from a 'hold' recommendation based solely on this filing.

Keywords

Century Therapeutics, IPSC, Brent Pfeiffenberger, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, CEO, Director